WHO official thinks the COVID-19 vaccine booster debate is all wrong

The World Health Organization's director of immunization, vaccination, and biologics argues it may be too early to push for population-level COVID-19 booster shots, especially when many people around the world have not even received their first dose.
There just isn't enough evidence right now to back up the need for widespread boosters in heavily vaccinated countries, director Kate O'Brien suggested in an interview with Stat News. Looking specifically at the two-dose mRNA vaccines produced by Pfizer and Moderna, O'Brien said the timing and rationale for third doses isn't really about "boosting," anyway. Instead, "it's actually about whether ... you need a third priming dose" for people who are immunocompromised. "For some vaccines ... there seems to be evidence coming forward, more about people who are having a failure of the primary series [of shots] and evidence on whether or not a third priming dose would help," she said.
With that in mind, a "much more important message" than whether all fully immunized folks need to get a booster is that "we have really have huge inequity right now in just getting primary doses to people," O'Brien continued.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The focus [of Covid vaccination] really is on reducing serious disease, hospitalizations, and death," she said. "And when you look at the deployment of the vaccines globally, a whole lot of those vaccines have gone to people who have extremely low risk of that happening, while at the same time there are huge numbers of people who do fall into that risk group who haven't been vaccinated. We're just really out of kilter here." Read O'Briens full interview at Stat News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Today's political cartoons - February 22, 2025
Cartoons Saturday's cartoons - bricking it, I can buy myself flowers, and more
By The Week US Published
-
5 exclusive cartoons about Trump and Putin negotiating peace
Cartoons Artists take on alternative timelines, missing participants, and more
By The Week US Published
-
The AI arms race
Talking Point The fixation on AI-powered economic growth risks drowning out concerns around the technology which have yet to be resolved
By The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published